載入...
Development of an Effective Therapy for CML
Targeted small molecule drugs have revolutionized treatment of chronic myeloid leukemia (CML) over the last decade. These agents interrupt a constitutively active BCR-ABL, the causative agent for CML, by interfering with ATP-dependent ABL tyrosine kinase. Although the efficacy of tyrosine kinase inh...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3251313/ https://ncbi.nlm.nih.gov/pubmed/22157291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0b013e318237e5b7 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|